Citations

Mayo Clinic

Clear

1703 citation(s) found for "Xu, Jean".

The Biological Reference Repository (BioR): a rapid and flexible system for genomics annotation
Kocher, Jean-Pierre A., Quest, Daniel, Meiners, Michael A., Moore, Raymond M. , Hossain, Asif, Hart, Steven N. , Dinu, Valentin , Quest, Daniel J, Duffy, Patrick, Rider, David, Duffy, Patrick Emmet , Rider, David A. , Dinu, Valentin , Hart, Steven N , Moore, Raymond

Bioinformatics | March 12, 2014 | Volume: 30 | Issue: 13 | Pages: 1920-1922

10.1093/bioinformatics/btu137 | PMID 24618464 Get It

Abstract Motivation: The Biological Reference Repository (BioR) is a toolkit for annotating variants. BioR stores public and user-specific annotation sources in indexed JSON-encoded flat files (catalogs). The BioR toolkit provides the functionality to combine and retrieve annotation from these catalogs via the command-line interface. Several catalogs from commonly used annotation sources and instructions for creating user-specific catalogs are provided. Commands from the toolkit can be combined with other UNIX commands for advanced annotation processing. We also provide instructions for the development of custom annotation pipelines. Availability and implementation: The package is implemented in Java and makes use of external tools written in Java and Perl. The toolkit can be executed on Mac OS X 10.5 and above or any Linux distribution. The BioR application, quickstart, and user guide documents and many biological examples are available at http://bioinformaticstools.mayo.edu . Contact: Kocher.JeanPierre@mayo.edu Supplementary information: Supplementary data are available at Bioinformatics online.
Frozen Section Pathology for Decision Making in Parotid Surgery
Olsen, Kerry D., Moore, Eric J. , Lewis, Jean E.

JAMA Otolaryngology–Head & Neck Surgery | March 10, 2014 | Volume: 139 | Issue: 12 | Pages: 1275

10.1001/jamaoto.2013.5217 | PMID 24136579 Get It

Estradiol, but not testosterone, heightens cortisol-mediated negative feedback on pulsatile ACTH secretion and ACTH approximate entropy in unstressed older men and women
Sharma, Animesh, Aoun, Paul , Wigham, Jean, Weist, Suanne M., Veldhuis, Johannes D. , Sharma, Animesh N

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | February 27, 2014 | Volume: 306 | Issue: 9 | Pages: R627-R635

10.1152/ajpregu.00551.2013 | PMID 24573184 Get It

How sex steroids modulate glucocorticoid feedback on the hypothalamic-pituitary-corticotrope (HPC) unit is controversial in humans. We postulated that testosterone (T) in men and estradiol (E2) in women govern unstressed cortisol-mediated negative feedback on ACTH secretion. To test this hypothesis, 24 men and 24 women age 58 ± 2.4 yr were pretreated with leuprolide and either sex steroid (E2 in women, T in men) or placebo addback. Placebo or ketoconazole (KTCZ) was administered overnight to inhibit adrenal steroidogenesis during overnight 14-h intravenous infusions of saline or cortisol in a continuous versus pulsatile manner to test for feedback differences. ACTH was measured every 10 min during the last 8 h of the infusions. The main outcome measures were mean ACTH concentrations, pulsatile ACTH secretion, and ACTH approximate entropy (ApEn). ACTH concentrations were lower in women than men ( P < 0.01), and in women in the E2+ compared with E2− group under both continuous ( P = 0.01) and pulsatile ( P = 0.006) cortisol feedback, despite higher cortisol binding globulin and lower free cortisol levels in women than men ( P < 0.01). In the combined groups, under both modes of cortisol addback, ACTH concentrations, pulsatile ACTH secretion, and ACTH secretory-burst mass correlated negatively and univariately with E2 levels (each P < 0.005). E2 also suppressed ACTH ApEn (process randomness) during continuous cortisol feedback ( P = 0.004). T had no univariate effect but was a positive correlate of ACTH when assessed jointly with E2 (negative) under cortisol pulses. In conclusion, sex steroids modulate selective gender-related hypothalamic-pituitary adrenal-axis adaptations to cortisol feedback in unstressed humans.
Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients
Geyer, Holly L. , Scherber, Robyn M. , Dueck, Amylou C. , Kiladjian, Jean‐Jacques , Xiao, Zhijian , Slot, Stefanie , Zweegman, Sonja , Sackmann, Federico, Fuentes, Ana Kerguelen, Hernández‐Maraver, Dolores , Döhner, Konstanze , Harrison, Claire , Radia, Deepti , Muxí, Pablo , Besses, Carlos , Cervantes, Francisco , Johansson, Peter , Andréasson, Björn , Rambaldi, Alessandro , Barbui, Tiziano , Passamonti, Francesco , Samuelsson, Jan , Birgegård, Gunnar , Zweegman, Sonja , Vannucchi, Alessandro M. , Mesa, Ruben A. , Dueck, A. C. , Kiladjian, Jean-Jacques , Rambaldi, Alessandro , Passamonti, Francesco

Blood | February 20, 2014 | Volume: 123 | Issue: 24 | Pages: 3803-3810

10.1182/blood-2013-09-527903 | PMID 24553173 Get It

Key Points Distinct clusters exist within polycythemia vera, essential thrombocythemia, and myelofibrosis. Clusters are not direct surrogates for current prognostic scores.
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Maurer, Matthew J. , Ghesquières, Hervé , Jais, Jean‐Philippe, Haïoun, Corinne , Thompson, Carrie A. , Delarue, Richard, Micallef, Ivana N. , Peyrade, Frédéric, Macon, William R. , Molina, Thierry Jo , Ketterer, Nicolas , Syrbu, Sergei , Fitoussi, Olivier , Kurtin, Paul J. , Allmer, Cristine, Nicolas‐Virelizier, Emmanuelle , Link, Brian K. , Salles, Gilles , Tilly, Hervé , Cerhan, James R. , Jaïs, Jean‐Philippe , Witzig, Thomas E. , Slager, Susan L. , Habermann, Thomas M. , Maurer, Matthew , Cerhan, James R , Link, Brian K , Salles, Gilles A , Syrbu, Sergei

Journal of Clinical Oncology | February 19, 2014 | Volume: 32 | Issue: 10 | Pages: 1066-1073

10.1200/jco.2013.51.5866 | PMID 24550425 Get It

Purpose Studies of diffuse large B-cell lymphoma (DLBCL) are typically evaluated by using a time-to-event approach with relapse, re-treatment, and death commonly used as the events. We evaluated the timing and type of events in newly diagnosed DLBCL and compared patient outcome with reference population data. Patients and Methods Patients with newly diagnosed DLBCL treated with immunochemotherapy were prospectively enrolled onto the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource (MER) and the North Central Cancer Treatment Group NCCTG-N0489 clinical trial from 2002 to 2009. Patient outcomes were evaluated at diagnosis and in the subsets of patients achieving event-free status at 12 months (EFS12) and 24 months (EFS24) from diagnosis. Overall survival was compared with age- and sex-matched population data. Results were replicated in an external validation cohort from the Groupe d'Etude des Lymphomes de l'Adulte (GELA) Lymphome Non Hodgkinien 2003 (LNH2003) program and a registry based in Lyon, France. Results In all, 767 patients with newly diagnosed DLBCL who had a median age of 63 years were enrolled onto the MER and NCCTG studies. At a median follow-up of 60 months (range, 8 to 116 months), 299 patients had an event and 210 patients had died. Patients achieving EFS24 had an overall survival equivalent to that of the age- and sex-matched general population (standardized mortality ratio [SMR], 1.18; P = .25). This result was confirmed in 820 patients from the GELA study and registry in Lyon (SMR, 1.09; P = .71). Simulation studies showed that EFS24 has comparable power to continuous EFS when evaluating clinical trials in DLBCL. Conclusion Patients with DLBCL who achieve EFS24 have a subsequent overall survival equivalent to that of the age- and sex-matched general population. EFS24 will be useful in patient counseling and should be considered as an end point for future studies of newly diagnosed DLBCL.
Murine Leukemia Virus Uses NXF1 for Nuclear Export of Spliced and Unspliced Viral Transcripts
Sakuma, Toshie, Davila, Jaime , Malcolm, Jessica A., Kocher, Jean-Pierre A., Tonne, Jason M., Ikeda, Yasuhiro , Davila, Jaime I

Journal of Virology | January 30, 2014 | Volume: 88 | Issue: 8 | Pages: 4069-4082

10.1128/jvi.03584-13 | PMID 24478440 Get It

ABSTRACT Intron-containing mRNAs are subject to restricted nuclear export in higher eukaryotes. Retroviral replication requires the nucleocytoplasmic transport of both spliced and unspliced RNA transcripts, and RNA export mechanisms of gammaretroviruses are poorly characterized. Here, we report the involvement of the nuclear export receptor NXF1/TAP in the nuclear export of gammaretroviral RNA transcripts. We identified a conserved cis -acting element in the pol gene of gammaretroviruses, including murine leukemia virus (MLV) and xenotropic murine leukemia virus (XMRV), named the CAE (cytoplasmic accumulation element). The CAE enhanced the cytoplasmic accumulation of viral RNA transcripts and the expression of viral proteins without significantly affecting the stability, splicing, or translation efficiency of the transcripts. Insertion of the CAE sequence also facilitated Rev-independent HIV Gag expression. We found that the CAE sequence interacted with NXF1, whereas disruption of NXF1 ablated CAE function. Thus, the CAE sequence mediates the cytoplasmic accumulation of gammaretroviral transcripts in an NXF1-dependent manner. Disruption of NXF1 expression impaired cytoplasmic accumulations of both spliced and unspliced RNA transcripts of XMRV and MLV, resulting in their nuclear retention or degradation. Thus, our results demonstrate that gammaretroviruses use NXF1 for the cytoplasmic accumulation of both spliced and nonspliced viral RNA transcripts. IMPORTANCE Murine leukemia virus (MLV) has been studied as one of the classic models of retrovirology. Although unspliced host messenger RNAs are rarely exported from the nucleus, MLV actively exports unspliced viral RNAs to the cytoplasm. Despite extensive studies, how MLV achieves this difficult task has remained a mystery. Here, we have studied the RNA export mechanism of MLV and found that (i) the genome contains a sequence which supports the efficient nuclear export of viral RNAs, (ii) the cellular factor NXF1 is involved in the nuclear export of both spliced and unspliced viral RNAs, and, finally, (iii) depletion of NXF1 results in nuclear retention or degradation of viral RNAs. Our study provides a novel insight into MLV nuclear export.
Genetic and biochemical analyses in dyslipidemic patients undergoing LDL apheresis
Saenger, Amy K., Train, Laura, Kotzer, Katrina E. , Lagerstedt, Susan A., Hornseth, Jean M, Basu, Ananda, Baudhuin, Linnea M. , Donato, Leslie J. , Winters, Jeffrey L.

Journal of Clinical Apheresis | January 13, 2014 | Volume: 29 | Issue: 5 | Pages: 256-265

10.1002/jca.21317 | PMID 24420163 Get It

Carney Complex, Peutz-Jeghers Syndrome, Cowden Disease, and Bannayan-Zonana Syndrome Share Cutaneous and Endocrine Manifestations, But Not Genetic Loci
Taymans, Susan E., Tomlinson, Ian , Marsh, Debbie J., Torpy, David J. , Giatzakis, Christoforos, Eccles, Diana M., Theaker, Jeffrey, Houlston, Richard S. , Blouin, Jean‐Louis , Basson, Craig T. , Carney, J. Aidan, Eccles, Diana , Stratakis, Constantine A. , Kirschner, Lawrence S. , Marsh, Debbie J., Eccles, Diana M., Antonarakis, Stylianos E. , Eng, Charis , Eccles, Diana , Houlston, Richard S

The Journal of Clinical Endocrinology & Metabolism | January 8, 2014 | Volume: 83 | Issue: 8 | Pages: 2972-2976

10.1210/jcem.83.8.5042 | PMID 9709978 Get It

Effect of the High-Affinity Estrogen Receptor Ligand ICI 182,780 on the Rat Tibia*
Sibonga, Jean D. , Dobnig, Harald , Harden, R., Turner, Russell T.

Endocrinology | January 8, 2014 | Volume: 139 | Issue: 9 | Pages: 3736-3742

10.1210/endo.139.9.6172 | PMID 9724025 Get It

Long-Term Mortality Associated With Left Ventricular Dysfunction in Mitral Regurgitation Due to Flail Leaflets
Tribouilloy, Christophe, Ruşinaru, Dan, Grigioni, Francesco , Vanoverschelde, Jean‐Louis , Aviérinos, Jean-François , Barbieri, Andréa , Pislaru, Sorin V. , Russo, Antonio , Théron, Alexis , Szymanski, Catherine, Enriquez‐Sarano, Maurice , Mantovani, Francesca , Meester, Christophe de , Tribouilloy, Christophe , Michelena, Héctor I. , Pasquet, Agnès , Lévy, Franck , Sabbah, Michael S. , Enriquez-Sarano, Maurice , Mantovani, Francesca , Barbieri, Andrea , Vanoverschelde, Jean-Louis , Théron, Alexis , Grigioni, Francesco

Circulation: Cardiovascular Imaging | December 21, 2013 | Volume: 7 | Issue: 2 | Pages: 363-370

10.1161/circimaging.113.001251 | PMID 24363357 Get It

Background— Ejection fraction (EF) as a marker of left ventricular (LV) dysfunction and the appropriate thresholds for diagnosing severe or mild/moderate LV dysfunction in mitral regurgitation are doubted and poorly followed in clinical practice. We aimed at assessing the role of EF in a large registry of organic mitral regurgitation to objectively establish thresholds for various degrees of LV dysfunction and to analyze whether mitral surgery remains beneficial in those subsets of patients. Methods and Results— We investigated the relation between EF and mortality in 1875 patients with mitral regurgitation due to flail leaflets in sinus rhythm (65±13 years; median EF, 66% [60%–71%]) enrolled in the Mitral Regurgitation International Database (MIDA) registry. With EF <60%, mortality after diagnosis increased precipitously under medical management (adjusted hazard ratio [HR], 1.59 [1.19–2.12]) and during the entire follow-up (adjusted HR, 1.51 [1.22–1.87]). Severe LV dysfunction, if defined by EF <30%, would affect a minuscule number of patients (0.3%). Conversely, EF <45% was more frequent (2.9%) and was associated with considerable mortality under medical management (adjusted HR, 2.43 [1.50–3.95]) and during the entire follow-up (adjusted HR, 2.46 [1.67–3.61]). The group with EF of 45% to 60% represented a large proportion of patients (23%), exhibited rarely overt symptoms, and had higher mortality compared with EF >60%. Above 60%, no EF threshold further determined survival. The benefit of surgery remained considerable in the groups with EF <45% (adjusted HR, 0.28 [0.17–0.56]) and with EF of 45% to 60% (adjusted HR, 0.34 [0.21–0.64]). Conclusions— EF is valuable in defining presence and severity of LV dysfunction in organic mitral regurgitation. Patients with EF <45% have severe LV dysfunction, catastrophic outcome under medical management, and should not be denied surgery. Although there is no survival gain with EF ranges >60%, with EF dropping <60%, mortality increases precipitously and prompt surgical referral is critical to outcome.